McKesson Q1 FY27: where the revenue came from and where it went
The whole income statement of McKesson for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Apr 1 – Jun 30, 2026
- Reported
- Aug 5, 2026
Revenue$105.38B
+8% year over year
Gross profit$3.69B
3% margin
Operating profit$1.32B
1% margin
Net profit$0.61B
1% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 105.38 | 100% | +8% |
| North american | 86.77 | 82% | |
| Oncology & multispecialty | 14.22 | 14% | |
| Medical-Surgical | 2.82 | 3% | |
| Prescription technology | 1.57 | 1% | |
| Cost of revenue | −101.70 | 97% | |
| Gross profit | 3.69 | 3% margin | +0pp |
| SG&A | −2.26 | 2% | +0pp |
| Other | −0.10 | 0% | +0pp |
| Operating profit | 1.32 | 1% margin | +0pp |
| Interest & other costs | −0.43 | ||
| Tax | −0.28 | ||
| Net profit | 0.61 | 1% margin | +0pp |
124 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest